Diabetes |
Blood Sugar; Diabetes Mellitus; Non-Insulin Dependent Diabetes Mellitus; Type II Diabetes |
Clinical Trial: Almonds and Pre-Diabetes
This study is not yet open for patient recruitment.
Verified by University of Medicine and Dentistry New Jersey December 2005
|
Purpose
Study Hypothesis: Daily consumption of almonds over 16-weeks will produce a decrease in HbA1c levels in adults with pre-diabetes.
Lay Summary: Persons developing type 2 diabetes mellitus (T2DM) will typically first have a condition called pre-diabetes. Lifestyle is a major factor that determines whether pre-diabetes becomes full T2DM. Lifestyle includes dietary habits and physical activity. Many people develop T2DM because of poor dietary habits and a sedentary lifestyle. Moreover, eating a high-fat, high-sugar diet can damage the blood vessels and increase the risk of strokes and heart attacks. A person’s diet may produce substances in the blood that can interfere with the production of insulin in the pancreas. Sometimes, these changes in the insulin producing cells are serious and can eventually interfere with how the cells in the body use blood sugar, which causes T2DM. Techniques are available to measure circulating substances in the blood of persons with pre-diabetes that may be associated with the development of T2DM. Laboratory research has shown that almonds contain high levels of important compounds that may influence the onset of heart disease and T2DM. A meal plan that includes almonds daily will be given to half of the study participants and the other participants will be given a meal plan that is “nut-free”. Because of the potential to delay the onset of heart disease and T2DM in some persons with pre-diabetes, this 16-week study will collect and analyze blood samples for changes that may make the person with pre-diabetes more likely to develop heart disease and T2DM. Blood samples will be collected at weeks 0, 8 and 16 to measure compounds that may be influenced by consuming almonds daily. This study will also attempt to understand other possible causes of heart disease and T2DM in persons with pre-diabetes; particularly those that might be related to body weight and body composition. Body composition techniques using very small amounts of electrical current are available to study body fat. Body weight, waist and hip measurements, blood pressure and body composition testing will be performed at the start of the study and every 4 weeks during the study. Lastly, these other possible causes of heart disease and T2DM will be investigated to look at relationships with the substances in the blood.
| Condition | Intervention |
|---|---|
| Diabetes | Behavior: Almonds in a calorie controlled diet |
MedlinePlus related topics: Diabetes
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Prospective Study
Official Title: The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes
Expected Total Enrollment: 184
Study start: January 2006
Eligibility
Inclusion Criteria:
• Age greater than 18 years • No self-reported allergy to almonds • No history of irritable bowel disease or diverticulitis that could be exacerbated by daily almond intake • Presence of pre-diabetes according to the 2005 American Diabetes Association diagnostic guidelines (fasting blood glucose between 100 to 125 mg/dl, or, casual blood glucose ≥ 140-199 mg/dl) • BMI 20-35 kg/m2 to enhance the generalizability of the study’s findings to the population of adults with pre-diabetes • Willingness to discontinue vitamin E supplement usage while enrolled in the study.
Exclusion Criteria:
- No concurrent use of corticosteroids or immunosuppressant medications (tacrolimus, cyclosporine, sirolimus, azathioprine, 6-mercaptopurine, mycophenolate moefitil, everolimus) in light of their effect on inflammatory biomarkers • No liver disease, renal disease and/or severe dyslipidemia (TG >400mg/dl or total cholesterol (TC) >300 mg/dl)
Location and Contact Information
New Jersey
UMDNJ, Newark, New Jersey, 07107, United States
David Bleich, MD, Sub-Investigator
Riva Touger-Decker, PhD, RD, Sub-Investigator
Barbara Greenberg, PhD, Sub-Investigator
Maya Raguwanshi, MD, Sub-Investigator
Julie O''''Sullivan Maillet, PhD, RD, Sub-Investigator
Michelle A Wien, DrPH, RD, Principal Investigator, University of Medicine and Dentistry New Jersey
More Information
Publications that report results of this study
Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Josse AR, Wong JM, de Souza R, Emam A, Parker TL, Li TJ, Josse RG, Leiter LA, Singer W, Connelly PW. Direct comparison of dietary portfolio vs statin on C-reactive protein. Eur J Clin Nutr. 2005 Jul;59(7):851-60.
Last Updated: December 28, 2005
Record first received: December 27, 2005
ClinicalTrials.gov Identifier: NCT00270985
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2006-01-10

Not Signed In -


